Search Results - "Fréchet Jachym, Mathilde"
-
1
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
ISSN: 1080-6040, 1080-6059, 1080-6059Published: United States U.S. National Center for Infectious Diseases 01.05.2019Published in Emerging infectious diseases (01.05.2019)“…Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis…”
Get full text
Journal Article -
2
Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019
ISSN: 1080-6040, 1080-6059, 1080-6059Published: United States U.S. National Center for Infectious Diseases 01.09.2022Published in Emerging infectious diseases (01.09.2022)“…Definitions of resistance in multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) have been updated. Pre-XDR TB,…”
Get full text
Journal Article -
3
Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia
ISSN: 1399-3003, 1399-3003Published: England 01.03.2018Published in The European respiratory journal (01.03.2018)Get more information
Journal Article -
4
Standardized Infliximab Regimen to Treat Severe Central Nervous System Tuberculosis: A Case Series of 18 Patients
ISSN: 2328-8957, 2328-8957Published: US Oxford University Press 01.08.2025Published in Open forum infectious diseases (01.08.2025)“…Abstract Background Morbidity associated with central nervous system tuberculosis (CNS TB) remains high due to persistent inflammation despite standard-of-care…”
Get full text
Journal Article -
5
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
ISSN: 1399-3003, 1399-3003Published: England 01.07.2020Published in The European respiratory journal (01.07.2020)Get more information
Journal Article -
6
Concomitant Multidrug-resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis
ISSN: 1080-6040, 1080-6059, 1080-6059Published: United States U.S. National Center for Infectious Diseases 01.03.2014Published in Emerging infectious diseases (01.03.2014)Get full text
Journal Article -
7
Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study
ISSN: 0163-4453, 1532-2742, 1532-2742Published: England Elsevier Ltd 01.06.2022Published in The Journal of infection (01.06.2022)“…ObjectivesLimited evidence is available on the co-administration of treatment for hepatitis C virus (HCV) and multidrug-resistant tuberculosis (MDR-TB). The…”
Get full text
Journal Article -
8
Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study
ISSN: 0954-6111, 1532-3064, 1532-3064Published: England Elsevier Ltd 01.11.2017Published in Respiratory medicine (01.11.2017)“…Europe has the highest documented caseload and greatest increase in multidrug and extensively drug-resistant tuberculosis (M/XDR-TB) of all World Health…”
Get full text
Journal Article -
9
Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France
ISSN: 2076-2607, 2076-2607Published: Switzerland MDPI AG 14.06.2022Published in Microorganisms (14.06.2022)“…The optimal treatment for osteoarticular infection due to multidrug-resistant tuberculosis strains (MDR-OATB) remains unclear. This study aims to evaluate the…”
Get full text
Journal Article -
10
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis
ISSN: 1399-3003, 1399-3003Published: England 01.03.2017Published in The European respiratory journal (01.03.2017)“…Bedaquiline, a recently approved drug for the treatment of multidrug-resistant tuberculosis (MDR-TB), is recommended for a duration of 24 weeks. There are…”
Get more information
Journal Article -
11
Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe
ISSN: 1073-449X, 1535-4970, 1535-4970Published: United States American Thoracic Society 15.10.2016Published in American journal of respiratory and critical care medicine (15.10.2016)Get full text
Journal Article -
12
Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment
ISSN: 1537-6591, 1537-6591Published: United States 08.02.2023Published in Clinical infectious diseases (08.02.2023)“…Treatment of multidrug-resistant (MDR) tuberculosis with linezolid is characterized by high rates of adverse events. Evidence on therapeutic drug monitoring to…”
Get more information
Journal Article -
13
Bedaquiline plus delamanid for XDR tuberculosis
ISSN: 1473-3099, 1474-4457, 1474-4457Published: United States Elsevier Ltd 01.03.2016Published in The Lancet infectious diseases (01.03.2016)“…The combination was initiated in a patient in whom an effective treatment cannot be designed, in the consideration that its potential life-saving benefits…”
Get full text
Journal Article -
14
Preventing Acquired Resistance to Bedaquiline and Delamanid in Multidrug-Resistant Tuberculosis Treatment Requires Optimal Management
ISSN: 1073-449X, 1535-4970, 1535-4970Published: United States American Thoracic Society 01.11.2016Published in American journal of respiratory and critical care medicine (01.11.2016)Get full text
Journal Article -
15
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?
ISSN: 1399-3003Published: England 01.08.2016Published in The European respiratory journal (01.08.2016)Get more information
Journal Article -
16
Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria
ISSN: 1073-449X, 1535-4970, 1535-4970Published: United States American Thoracic Society 01.12.2017Published in American journal of respiratory and critical care medicine (01.12.2017)Get full text
Journal Article -
17
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors
ISSN: 1399-3003, 1399-3003Published: England 01.03.2017Published in The European respiratory journal (01.03.2017)Get more information
Journal Article -
18
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium
ISSN: 1815-7920, 1815-7920Published: France 01.10.2019Published in The international journal of tuberculosis and lung disease (01.10.2019)“…The World Health Organization (WHO) recommends that multidrug-resistant tuberculosis (MDR-TB) treatment should be managed in collaboration with…”
Get more information
Journal Article